Africa50, AfricInvest & Ohara Pharmaceutical’s investment in Africa Healthcare Network’s operations in Tanzania, Rwanda, Kenya and Mauritius for USD 20 million

Lead party: Africa50 (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Africa Healthcare Network (private company) · Sector: Healthcare, Primary Care Providers, Specialty Healthcare Providers · Countries of operation: Kenya, Rwanda, Mauritius, Tanzania Transaction type: Investment, Debt Financing, Exit · Asset class: Venture Capital, Private Equity, Corporate Transactions,…


Lead party: Africa50 (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Africa Healthcare Network (private company) · Sector: Healthcare, Primary Care Providers, Specialty Healthcare Providers · Countries of operation: Kenya, Rwanda, Mauritius, Tanzania

Transaction type: Investment, Debt Financing, Exit · Asset class: Venture Capital, Private Equity, Corporate Transactions, Infrastructure & Project Finance · Strategy: Direct Lending, Secondary Sale · Instrument: Equity, Debt · Round: Series B · Deal amount: US$20m · Fund: Africa50 Principal Investment Fund

Lead investor/buyer: Africa50, AfricInvest Capital Partners LLC · Investors/buyers: Africa50, AfricInvest Capital Partners LLC, Ohara Pharmaceutical Co., Ltd. · Sellers: AAIC Investment Pte. Ltd.

Legal advisers: not identified in the source record.

Source: announced 20 November 2023. Original announcement: africinvest.com.